Molecular Pharming

A Global Strategic Business Report

MCP37427

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7143

EXECUTIVE POOL

5850

PRICE

812

EXPERT INPUTS

39

COMPANIES

426

DATA TABLES

495

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Molecular Pharming Market to Reach US$2.3 Billion by 2030

The global market for Molecular Pharming estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Maize Crop, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$607.4 Million by the end of the analysis period. Growth in the Barley Crop segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$449.8 Million While China is Forecast to Grow at 9.1% CAGR

The Molecular Pharming market in the U.S. is estimated at US$449.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$468.3 Million by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Molecular Pharming Market - Key Trends & Drivers Summarized

What Is Molecular Pharming and Why Is It Gaining Momentum?

Molecular pharming refers to the use of genetically modified plants to produce pharmaceutical substances such as vaccines, antibodies, enzymes, and therapeutic proteins. This technique combines plant biotechnology with pharmaceutical manufacturing, allowing plants to function as biofactories for complex biologics. Molecular pharming is gaining attention for its potential to offer scalable, low-cost, and contamination-resistant alternatives to traditional cell-based or microbial production systems.

By using crops such as tobacco, maize, rice, and even lettuce, researchers can express specific genes that encode therapeutic proteins. These proteins are then harvested and purified for medical use. Molecular pharming is particularly suited for producing biologics in large volumes, especially in low-resource settings or during health emergencies where rapid and cost-effective manufacturing is critical. Its growing relevance lies in its ability to meet rising global demand for biologics while bypassing the limitations of conventional production infrastructure.

How Are Technologies and Processes Advancing in This Field?

Advancements in genetic engineering, plant transformation techniques, and protein expression systems have significantly improved the efficiency and viability of molecular pharming. Technologies such as Agrobacterium-mediated gene transfer, transient expression using viral vectors, and CRISPR-based gene editing are helping optimize yields and reduce development time. Purification processes have also evolved, with new methods enabling the recovery of high-purity proteins without damaging their structure or function.

Innovations now allow expression of monoclonal antibodies, insulin analogs, and enzyme replacement therapies directly within plant tissues. Some approaches use hydroponically grown plants in contained environments to maintain consistency and meet pharmaceutical-grade standards. Regulatory frameworks are gradually adapting to support commercial scale-up, with a few plant-derived biologics already approved for use. These developments are expanding confidence in plant-based production systems, especially for niche or high-volume therapeutic needs.

Where Is Molecular Pharming Being Applied and Who Are the Key Stakeholders?

Molecular pharming is being applied in several areas including vaccine development, infectious disease treatment, cancer therapy, and rare genetic disorders. One of its major successes has been the production of antibodies against Ebola and rabies viruses. Research institutions, biotech firms, and pharmaceutical companies are investing in plant-based platforms to diversify their biologics pipelines and respond to evolving global health priorities.

Academic research centers play a central role in early-stage development and proof-of-concept studies, while private-sector players focus on scale-up, formulation, and regulatory approval. Governments and health organizations in developing regions view molecular pharming as a means to achieve greater self-reliance in essential medicine production. Partnerships between public institutions and biotech companies are becoming more common, especially for producing vaccines and treatments for diseases that lack commercial incentives under traditional models.

What Factors Are Driving Growth In The Molecular Pharming Market?

Growth in the molecular pharming market is driven by several factors including rising demand for biologics, limitations of traditional manufacturing systems, and the need for flexible, scalable production platforms. Molecular pharming offers cost advantages in terms of infrastructure and raw materials, making it attractive for producing affordable therapies in developing countries. The ability to rapidly deploy production in response to emerging infectious diseases is another key benefit driving interest.

Advances in plant biotechnology, increased investment in synthetic biology, and progress in downstream purification technologies are helping overcome past limitations related to yield and consistency. Growing support from regulatory bodies and public health institutions is also encouraging wider adoption. As global healthcare systems look for resilient and decentralized manufacturing solutions, molecular pharming is emerging as a viable approach to meeting future therapeutic needs with greater speed and sustainability.

SCOPE OF STUDY

The report analyzes the Molecular Pharming market by the following Segments, and Geographic Regions/Countries:

Segments:

Crop Source (Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop, Alfalfa Crop); Technology (Gene Gun Technology, Agro infiltration Technology, Electroporation Technology, Agrobacterium-Mediated Gene Transfer Technology, Other Technologies); Application (Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application, Other Applications); End-Use (Biotech & Pharma Companies End-Use, CROs End-Use, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Agrenvec S.L.; Avaxin Biologics; Baiya Phytopharm; BioBetter Ltd.; Bright Biotech; Cape Bio Pharms (Cape Biologix Tech.); Diamante S.r.l.; Elo Life Systems; Leaf Expression Systems; Medicago Inc.; Miruku; Moolec Science SA; MOZZA (Mozza Foods); Nobell Foods; ORF Genetics hf.; PlantForm Corporation; Planet Biotechnology Inc.; ProdiGene Inc.; Protalix Biotherapeutics, Inc.; Tiamat Sciences Corp.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Molecular Pharming – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 39 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Growing Demand for Cost-Effective Biopharmaceuticals Propels Adoption of Molecular Pharming Technologies

Rising Interest in Plant-Based Protein Expression Systems Strengthens Business Case for Alternative Drug Production

Expansion of Therapeutic Protein and Vaccine Development Drives Innovation in Molecular Pharming Platforms

Reduced Risk of Human Pathogen Contamination in Plant Systems Accelerates Regulatory Acceptance

Technological Advancements in Gene Editing and Plant Transformation Enhance Efficiency and Product Yield

Growth in Monoclonal Antibody Research Fuels Demand for Scalable Plant-Based Expression Systems

Increasing Pressure to Lower Biologic Drug Production Costs Spurs Investment in Molecular Pharming Startups

Global Vaccine Access Initiatives Highlight Potential of Plant-Derived Vaccines for Rapid, Scalable Deployment

Expansion of Biodefense and Pandemic Preparedness Programs Throws Spotlight on Fast-Track Production Methods

Growing Need for Cold Chain-Free Biologics Enhances Suitability of Plant-Based Pharmaceutical Products

Increased Application of Molecular Pharming in Veterinary Biologics Broadens End-Use Market Scope

Demand for Plant-Derived Enzymes and Industrial Proteins Drives Cross-Sector Adoption

4. GLOBAL MARKET PERSPECTIVE

World Molecular Pharming Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

World Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Molecular Pharming by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Maize Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Maize Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Maize Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Barley Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Barley Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Barley Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Tobacco Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Tobacco Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Tobacco Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Safflower Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Safflower Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Safflower Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Rice Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Rice Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Rice Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Alfalfa Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Alfalfa Crop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Alfalfa Crop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Agrobacterium-Mediated Gene Transfer Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Gene Gun Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Gene Gun Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Gene Gun Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Agro infiltration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Agro infiltration Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Agro infiltration Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Electroporation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Electroporation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Electroporation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Recombinant Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Recombinant Antibodies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Recombinant Antibodies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Hormones Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Hormones Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Industrial Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Industrial Enzymes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Industrial Enzymes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Proteins & Protein-based Materials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Proteins & Protein-based Materials Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Proteins & Protein-based Materials Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Technical Reagents Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Technical Reagents Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Technical Reagents Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Biotech & Pharma Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Biotech & Pharma Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

JAPAN

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

CHINA

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

EUROPE

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe Historic Review for Molecular Pharming by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

FRANCE

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

GERMANY

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

UNITED KINGDOM

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

ASIA-PACIFIC

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Molecular Pharming by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

AUSTRALIA

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

INDIA

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

LATIN AMERICA

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Molecular Pharming by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

MIDDLE EAST

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Molecular Pharming by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Molecular Pharming by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

AFRICA

Molecular Pharming Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Molecular Pharming by Crop Source - Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Molecular Pharming by Crop Source - Percentage Breakdown of Value Sales for Maize Crop, Barley Crop, Tobacco Crop, Safflower Crop, Rice Crop and Alfalfa Crop for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Molecular Pharming by Technology - Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Molecular Pharming by Technology - Percentage Breakdown of Value Sales for Agrobacterium-Mediated Gene Transfer Technology, Other Technologies, Gene Gun Technology, Agro infiltration Technology and Electroporation Technology for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Molecular Pharming by Application - Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Molecular Pharming by Application - Percentage Breakdown of Value Sales for Recombinant Antibodies Application, Hormones Application, Vaccines Application, Industrial Enzymes Application, Proteins & Protein-based Materials Application, Technical Reagents Application and Other Applications for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Molecular Pharming by End-Use - Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Molecular Pharming by End-Use - Percentage Breakdown of Value Sales for Biotech & Pharma Companies End-Use, CROs End-Use and Other End-Uses for the Years 2014, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll